Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Enhance Skin Products Inc (EHSK)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
338.3
|
M
| |
|
|
| Market cap: |
$1.25
|
M
| |
|
|
|
Net debt:
|
$18.2
|
k
| |
|
|
|
EV:
|
$1.27
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($2.9)
|
M
| |
|
|
|
EBIT
|
($2.9)
|
M
| |
|
|
| EPS |
$0.00
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Apr-30-16 | Apr-30-15 | Apr-30-14 | Apr-30-13 | Apr-30-12 | Apr-30-11 | Apr-30-10 | Apr-30-09 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 |
| Revenue growth | -16.0% | -32.5% | -65.0% | 950.7% | -100.4% | -5197.1% | | -100.0% |
| Cost of goods sold | 0.5 | 0.0 | 0.3 | 0.2 | 0.8 | 0.0 | 0.0 | 0.0 |
| Gross profit | -0.5 | 0.0 | -0.3 | -0.2 | -0.8 | -0.1 | 0.0 | 0.0 |
| Gross margin | -76886.5% | 100.0% | -24599.9% | -7923.2% | -273207.8% | 103.5% | 82.3% | |
| Selling, general and administrative | | | 0.0 | 0.0 | 0.0 | 0.8 | | |
| Sales and marketing | 0.0 | 0.0 | 0.0 | 0.0 | | | 0.1 | 0.2 |
| Research and development | | | | | | | | 0.0 |
| General and administrative | 0.5 | 0.1 | 0.0 | 0.0 | | | 0.6 | 0.4 |
| EBITA | -0.5 | -0.1 | -0.3 | -0.2 | -0.8 | -0.9 | -0.7 | -0.7 |
| EBITA margin | -76886.5% | -12366.8% | -24599.9% | -7923.2% | -272034.4% | 1273.7% | -53006.9% | |
| Amortization of intangibles | | | | | | 0.0 | 0.0 | |
| EBIT | -0.5 | -0.1 | -0.3 | -0.2 | -0.8 | -0.9 | -0.7 | -0.7 |
| EBIT margin | -76886.5% | -12366.8% | -24599.9% | -7923.2% | -272034.4% | 1288.2% | -53744.0% | |
| Pre-tax income | -0.6 | -0.1 | -0.3 | 1.4 | -0.8 | -1.0 | -0.7 | -0.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -0.6 | -0.1 | -0.3 | 1.4 | -0.8 | -1.0 | -0.7 | -0.7 |
| Net margin | -99959.2% | -15751.5% | -27339.3% | 44981.4% | -273207.8% | 1454.5% | -53719.0% | |
| |
| Diluted EPS | ($0.01) | $0.00 | $0.00 | $0.03 | ($0.02) | ($0.02) | ($0.02) | $0.00 |
| Shares outstanding (diluted) | 106.7 | 101.0 | 85.2 | 54.3 | 53.3 | 51.8 | 49.3 | 35.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|